Peptoid Efficacy against Polymicrobial Biofilms Determined by Using Propidium Monoazide‐Modified Quantitative PCR

Biofilms containing Candida albicans are responsible for a wide variety of clinical infections. The protective effects of the biofilm matrix, the low metabolic activity of microorganisms within a biofilm and their high mutation rate, significantly enhance the resistance of biofilms to conventional antimicrobial treatments. Peptoids are peptide‐mimics that share many features of host defence antimicrobial peptides but have increased resistance to proteases and therefore have better stability in vivo. The activity of a library of peptoids was tested against monospecies and polymicrobial bacterial/fungal biofilms. Selected peptoids showed significant bactericidal and fungicidal activity against the polymicrobial biofilms. This coupled with low cytotoxicity suggests that peptoids could offer a new option for the treatment of clinically relevant polymicrobial infections.

[1]  P. Denny,et al.  Enlarging the chemical space of anti-leishmanials: a structure–activity relationship study of peptoids against Leishmania mexicana, a causative agent of cutaneous leishmaniasis , 2016 .

[2]  R. Zuckermann,et al.  Structure-Activity Relationship Study of Novel Peptoids That Mimic the Structure of Antimicrobial Peptides , 2015, Antimicrobial Agents and Chemotherapy.

[3]  T. Coenye,et al.  Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR , 2015, PeerJ.

[4]  P. Denny,et al.  Investigating the Anti‐leishmanial Effects of Linear Peptoids , 2015, ChemMedChem.

[5]  R. Ryan,et al.  Polybacterial human disease: the ills of social networking , 2014, Trends in microbiology.

[6]  Laam Li,et al.  The importance of the viable but non-culturable state in human bacterial pathogens , 2014, Front. Microbiol..

[7]  Maelíosa T. C. McCrudden,et al.  The Host Defence Peptide LL-37 is Susceptible to Proteolytic Degradation by Wound Fluid Isolated from Foot Ulcers of Diabetic Patients , 2014, International Journal of Peptide Research and Therapeutics.

[8]  W. Bowen,et al.  Symbiotic Relationship between Streptococcus mutans and Candida albicans Synergizes Virulence of Plaque Biofilms In Vivo , 2014, Infection and Immunity.

[9]  J. Haldar,et al.  Small molecular antibacterial peptoid mimics: the simpler the better! , 2014, Journal of medicinal chemistry.

[10]  Ildinete Silva-Pereira,et al.  Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance , 2013, Front. Microbiol..

[11]  Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans , 2013, BMC Microbiology.

[12]  Maelíosa T. C. McCrudden,et al.  LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid. , 2013, Journal of clinical periodontology.

[13]  M. Ray,et al.  Polymicrobial Versus Monomicrobial Keratitis: A Retrospective Comparative Study , 2013, Eye & contact lens.

[14]  J. Trevors,et al.  Optimization, validation, and application of a real-time PCR protocol for quantification of viable bacterial cells in municipal sewage sludge and biosolids using reporter genes and Escherichia coli , 2013, Journal of Industrial Microbiology & Biotechnology.

[15]  G. Donelli,et al.  Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. , 2013, The Journal of antimicrobial chemotherapy.

[16]  D. Timson,et al.  IQ-motif peptides as novel anti-microbial agents. , 2013, Biochimie.

[17]  N. Bernardineli,et al.  Antimicrobial activity of calcium hydroxide and chlorhexidine on intratubular Candida albicans , 2013, International Journal of Oral Science.

[18]  Ehud Banin,et al.  Multi-species biofilms: living with friendly neighbors. , 2012, FEMS microbiology reviews.

[19]  Marc Torrent,et al.  Antimicrobial peptide action on parasites. , 2012, Current drug targets.

[20]  A. Barron,et al.  In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids. , 2012, Bioconjugate chemistry.

[21]  K. Kirshenbaum,et al.  A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents , 2012, ChemMedChem.

[22]  M. Harriott,et al.  Importance of Candida-bacterial polymicrobial biofilms in disease. , 2011, Trends in microbiology.

[23]  K. Brogden,et al.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? , 2011, International journal of antimicrobial agents.

[24]  Christopher H. Contag,et al.  Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis , 2011, Antimicrobial Agents and Chemotherapy.

[25]  A. Spormann,et al.  Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms , 2011, Antimicrobial Agents and Chemotherapy.

[26]  David W Williams,et al.  Molecular Analysis of Microbial Communities in Endotracheal Tube Biofilms , 2011, PloS one.

[27]  Dong Hyuck Lee,et al.  Quantitative detection of residual E. coli host cell DNA by real-time PCR. , 2010, Journal of microbiology and biotechnology.

[28]  H. Flemming,et al.  The biofilm matrix , 2010, Nature Reviews Microbiology.

[29]  B. Peters,et al.  Microbial interactions and differential protein expression in Staphylococcus aureus –Candida albicans dual-species biofilms , 2010, FEMS immunology and medical microbiology.

[30]  M. Harriott,et al.  Ability of Candida albicans Mutants To Induce Staphylococcus aureus Vancomycin Resistance during Polymicrobial Biofilm Formation , 2010, Antimicrobial Agents and Chemotherapy.

[31]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[32]  B. Peters,et al.  Cross-kingdom interactions: Candida albicans and bacteria. , 2009, FEMS microbiology letters.

[33]  W. Shi,et al.  Design and activity of a 'dual-targeted' antimicrobial peptide. , 2009, International journal of antimicrobial agents.

[34]  T. Kodadek,et al.  Peptoids as potential therapeutics. , 2009, Current opinion in molecular therapeutics.

[35]  Anne K Camper,et al.  Novel approaches toward preferential detection of viable cells using nucleic acid amplification techniques. , 2009, FEMS microbiology letters.

[36]  J. Lopez-Ribot,et al.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. , 2008, Nature protocols.

[37]  P. Hansen,et al.  Antimicrobial Activities of Twenty Lysine-Peptoid Hybrids against Clinically Relevant Bacteria and Fungi , 2008, Chemotherapy.

[38]  A. Barron,et al.  Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides , 2008, Proceedings of the National Academy of Sciences.

[39]  Fionnuala T Lundy,et al.  Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. , 2008, Molecular immunology.

[40]  A. Hirschl,et al.  Development of Novel Real-Time PCR Assays for Detection and Differentiation of Eleven Medically Important Aspergillus and Candida Species in Clinical Specimens , 2007, Journal of Clinical Microbiology.

[41]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[42]  R. Hancock,et al.  Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. , 2006, Biochimica et biophysica acta.

[43]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[44]  T. Falla,et al.  Antimicrobial peptides: therapeutic potential , 2006, Expert opinion on pharmacotherapy.

[45]  G. Horsman,et al.  Development of a Triplex Real-Time PCR Assay for Detection of Panton-Valentine Leukocidin Toxin Genes in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[46]  C. E. Taylor,et al.  Human polymicrobial infections , 2005, The Lancet.

[47]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[48]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[49]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[50]  H. Jenkinson,et al.  Interactions between Candida Species and Bacteria in Mixed Infections , 2002 .

[51]  M. Poot,et al.  Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain , 1997, Applied and environmental microbiology.

[52]  Stephen B. H. Kent,et al.  Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis , 1992 .